Piper Jaffray Downgrades Glycomimetics (GLYC) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Wall St futures tick higher as oil retreats ahead of inflation data
- Oil falls on weaker demand outlook and higher US stocks
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Birkenstock surges on revenue beat, higher full-year outlook
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Glycomimetics (GLYC) PT Lowered to $18 at H.C. Wainwright
August 5, 2019 7:23 AM EDTH.C. Wainwright analyst Edward White lowered the price target on Glycomimetics (NASDAQ: GLYC) to $18.00 (from $23.00) while maintaining a Buy rating.
... MoreGlycoMimetics (GLYC) Announces Pfizer's (PFE) Phase 3 Clinical Trial Evaluating Rivipansel in SCD Did Not Meet Endpoints (Earlier)
August 5, 2019 6:18 AM EDTGlycoMimetics, Inc. (Nasdaq: GLYC) reported that Pfizer Inc. (NYSE: PFE) announced today that the Phase 3 Rivipansel (GMI-1070): Evaluating... More
Glycomimetics (GLYC) PT Lowered to $14 at Stifel
August 5, 2019 2:57 AM EDTStifel analyst Stephen Willey lowered the price target on Glycomimetics (NASDAQ: GLYC) to $14.00 (from $21.00) while maintaining a Buy rating.
... MoreSunTrust Downgrades Glycomimetics (GLYC) to Hold
August 5, 2019 2:55 AM EDTSunTrust downgraded Glycomimetics (NASDAQ: GLYC) from Buy to Hold with a price target of $5.00 (from $23.00).
For an analyst ratings summary and ratings history on Glycomimetics click here. For more ratings news on Glycomimetics click here.
Shares of Glycomimetics closed at $6.00 yesterday.
... More